Huangshan Novel Co (002014) Fair Value & Analysis
Consumer Cyclical · CN · Market cap 6.6B CNY
Fair value as of: Jul 21, 2026
From 24 valuation models · updated 20 days ago
Share price −0.1% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- A fairly wide model range (¥6.19 to ¥14.43) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range ¥4.83 – ¥12.50 · fair‑value band ¥6.19 – ¥14.43 · the ¥10.97 price screens above the ¥10.12 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
Huangshan Novel Co (002014) currently trades at ¥10.97, while our model-based Fair Value estimate is ¥10.12, implying the stock looks roughly 7.8% fairly valued today. The Quality Score stands at 63/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Huangshan Novel Co generated revenue of 3.8B CNY at a net margin of 11.5%. Revenue grew 10.8% year over year. It earns a return on equity of 16.7%. Net debt stands at 229M CNY. Fundamentals as of Jul 21, 2026
Our scenario range runs from ¥6.19 (bear case) to ¥14.43 (bull case); at ¥10.97, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 13% below its 52-week high and 9% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -22% fair-value upside, at -8%, 002014 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Multiples (¥11.90) versus Asset-Based (¥2.71). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 62 · Market factors (momentum, volatility) 51
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Huangshan Novel Co.,Ltd manufactures and sells packaging materials in China and internationally. The company's packaging materials include plastic color-printing, laminating flexible, vacuum metallized and multi-functional film, medical packaging, breathable and protective membrane, and injection molding materials.
Full company description
Huangshan Novel Co.,Ltd manufactures and sells packaging materials in China and internationally. The company's packaging materials include plastic color-printing, laminating flexible, vacuum metallized and multi-functional film, medical packaging, breathable and protective membrane, and injection molding materials. Its products are used in food, dairy, pet food, daily chemicals, pharmaceutical, agrochemicals, electronics, architectural, building materials, and other applications. The company also exports its products to Europe, America, Mexico, Japan, the Middle East, and rest of Asia. The company was founded in 1992 and is headquartered in Huangshan City, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Huangshan Novel Co reported revenue of ¥3.7B in FY2025 versus ¥3.0B in FY2021, a compound +5.3%/yr. Reported net income was ¥438M in FY2025, compounding +8.5%/yr from FY2021.
Watch 002014: get an alert when its fair value changes →
Peer Group
Packaging & Containers · 273 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaging & Containers median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 35/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Packaging & Containers stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Stora Enso Oyj STER | kr 101.90 | kr 126.39 | +24% |
| ShenZhen YUTO Packaging Technology Co 002831 | ¥29.10 | ¥20.88 | -28% |
| SCG Packaging Public Company SCGP | 29.00 THB | 16.12 THB | -44% |
| AblePrint Technology Co 7734 | 2,850 TWD | 661.69 TWD | -77% |
| PT Fajar Surya Wisesa Tbk, FASW | 5,312 IDR | 1,194 IDR | -78% |
| Taiwan Hon Chuan Enterprise Co 9939 | 132.50 TWD | 127.06 TWD | -4% |
| Time Technoplast Limited TIMETECHNO | ₹206.82 | ₹161.42 | -22% |
| EPL Limited 500135 | ₹222.25 | ₹111.65 | -50% |
| Ton Yi Industrial Corp 9907 | 15.15 TWD | 23.17 TWD | +53% |
| Dongwon Systems Corporation 014820 | 19,330 KRW | 31,473 KRW | +63% |
Compare Huangshan Novel Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Huangshan Novel Co (002014) overvalued or undervalued?
What is the fair value of 002014?
What is the quality score of 002014?
What is the revenue of Huangshan Novel Co (002014)?
What is the net profit margin of 002014?
Does Huangshan Novel Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Huangshan Novel Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.